Results 241 to 250 of about 32,790 (255)

Furanocoumarins: Novel topoisomerase I inhibitors from Ruta graveolens L.

Bioorganic and Medicinal Chemistry, 2009
Nutan Malpathak
exaly  

Recent Advances in Use of Topoisomerase Inhibitors in Combination Cancer Therapy

Current Topics in Medicinal Chemistry, 2019
Wenjie Wang, Yuk-Ching Tse-Dinh
exaly  

Some new bi- and ter-benzimidazole derivatives as topoisomerase I inhibitors

Il Farmaco, 2003
I Yalcin
exaly  

Topoisomerase Inhibitors and Targeted Delivery in Cancer Therapy

Current Topics in Medicinal Chemistry, 2019
Changshou Gao
exaly  

Topoisomerase II inhibitors in AML: past, present, and future

Expert Opinion on Pharmacotherapy, 2019
Minas P Economides, Deborah Mccue, Gautam Borthakur   +2 more
exaly  

Topoisomerase‐I Inhibitors in the Management of Colon Cancer

Annals of the New York Academy of Sciences, 1996
openaire   +2 more sources

ATP-competitive DNA gyrase and topoisomerase IV inhibitors as antibacterial agents

Expert Opinion on Therapeutic Patents, 2019
Martina Ďurčík, Tihomir Tomasic, Nace Zidar   +2 more
exaly  

DNA topoisomerase I inhibitors.

Cancer chemotherapy and biological response modifiers, 1998
C H, Takimoto, L V, Kieffer, S G, Arbuck
openaire   +1 more source

Emerging DNA topoisomerase inhibitors as anticancer drugs

Expert Opinion on Emerging Drugs, 2004
William A Denny
exaly  

Discovery of a new class of catalytic topoisomerase II inhibitors targeting the ATP-binding site by structure based design. Part I

Bioorganic and Medicinal Chemistry Letters, 2009
Pascal Furet, Joseph Schoepfer, Thomas Radimerski   +2 more
exaly